News
Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...
The kitchen clock blinks 10:47 p.m. A ten-year-old polishes off reheated pizza while scrolling TikTok, because dinner was ...
Dr. Iris Shai says ‘We must stop equating the scale with success’ as healthy habits create improvements even if not ...
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in ...
Obesity: Researchers Discover a Cause of Leptin Resistance -- And How to Reverse It Mar. 4, 2025 — Most obese patients grow resistant to satiety signals from the hormone leptin.
We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results